Alzai Health Corp.

As of April 30, 2026, Alzai Health Corp. has 53.28M shares outstanding.

As of April 30, 2026, Alzai Health Corp. maintains a current ratio of 0.33, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -63.14, indicating conservative leverage, while an interest coverage ratio of -105.93 demonstrates limited ability to service its debt obligations.

Over the twelve months ended April 30, 2026, Alzai Health Corp. generated 27,039.00 in revenue and converted that into -3.68M in net income, yielding earnings per share of -0.07. EBITDA reached -3.61M, while operating income came in at -3.62M.

As of April 30, 2026, Alzai Health Corp. holds 268,074.00 in cash and equivalents against 833,889.00 in total debt, resulting in a net debt position of 565,815.00. Total book value stands at -1.32M, with working capital of -870,610.00 providing operational flexibility.

Alzai Health Corp. produced -2.59M in operating cash flow over the twelve months ended April 30, 2026. After subtracting -19,405.00 in capital expenditures, free cash flow totaled -2.61M - equivalent to -0.05 per share.

These figures cover the twelve months ended April 30, 2026. The operating margin of -13,405.82 and net profit margin of -13,593.12 provide insight into operational efficiency.